East Asia VC Funds

3E Bioventures Capital is a prominent venture capital firm specializing in the life sciences sector, focusing on innovative therapeutic drugs and disruptive med-tech. Founded with a mission encapsulated in their name—Expertise, Efficiency, Execution—3E Bioventures actively invests in global health innovators and TechBio, aiming to disrupt conventional paradigms by integrating biology with technology​​. Notable investments include Aravive, which develops biologic drugs targeting tumor metastasis, and C4 Therapeutics, which pioneers small-molecule drugs that degrade disease-causing proteins. Their portfolio also boasts companies like Cytek, which offers a transformative flow cytometry platform, and Twist Bioscience, known for its advanced DNA synthesis technology​​. Geographically, 3E Bioventures operates with a global perspective, maintaining a strong presence in the US and China. They often participate in early-stage and growth-stage investments, providing significant support in both capital and strategic guidance​​. The firm’s team includes experienced professionals such as Li Jing, Frank Yan, and Linda Liu, who leverage their deep industry knowledge to support portfolio companies effectively. They emphasize a science-driven, entrepreneur-friendly approach, working closely with research institutions and companies to address unmet medical needs​. For startups seeking investment, 3E Bioventures looks for breakthrough innovations in biotech and med-tech, focusing on areas with strong medical needs and the potential for significant impact. They prefer to engage with companies that align with their strategic goals and demonstrate a clear pathway to success​​.

Abies Ventures is a Tokyo-based venture capital firm that specializes in deep tech investments, aiming to tackle global issues like environmental degradation and food shortages through science and advanced technologies. Established in 2017, the firm focuses on early-stage companies with innovative solutions in areas such as AI, robotics, quantum computing, and biotech. Their portfolio includes cutting-edge startups like Synspective, Telexistence, and Mighty Buildings, reflecting their commitment to building sustainable, tech-driven solutions. Abies Ventures leverages its strong global network, partnering with large corporations, research institutes, and government agencies to help startups scale internationally. The fund is led by experienced venture founders like Fuyuki Yamaguchi and Sota Nagano, who bring extensive expertise in venture investment and scaling companies across Japan and the U.S. Their investment strategy centers on fostering deep tech companies with high impact potential, particularly in areas where finance, technology, and market dynamics may not always align. Abies Ventures helps bridge these gaps by providing strategic advice and connecting startups with key players to enhance their growth trajectory​.

Accion Venture Lab is an early-stage venture fund focused on empowering inclusive fintech startups that serve underserved and low-income populations globally. Established as part of Accion, a nonprofit dedicated to financial inclusion, Venture Lab provides seed-first capital paired with extensive strategic and operational support to help startups scale and overcome early challenges. Their diverse portfolio features innovative companies like Apollo Agriculture, which offers tech-driven financing to smallholder farmers in Kenya and Zambia, and Bababos, an Indonesian platform that supports small-scale manufacturers with raw materials and financing solutions. With a geographic reach that spans Latin America, the Caribbean, sub-Saharan Africa, the Middle East, North Africa, Southeast Asia, and even parts of the U.S., Accion Venture Lab's commitment is global. The fund targets industries such as digital lending, insurtech, personal financial management, and MSME-focused solutions, identifying startups with a mission to address systemic barriers to financial access. Their strategy is unique in that they prefer being the first institutional investor, ensuring startups receive not just capital but high-touch mentorship and strategic guidance. In 2019, Accion Venture Lab boosted its support efforts by launching a $23 million fund aimed at deepening their investment into inclusive fintech. Their approach prioritizes not only financial backing but also leveraging their deep-rooted expertise in financial inclusion to provide hands-on operational assistance. The team is led by seasoned Managing Partners Amee Parbhoo and Rahil Rangwala, who bring years of experience in fintech, impact investing, and scaling social enterprises. Founders looking for support from Venture Lab should demonstrate impactful, scalable solutions with clear pathways to financial inclusion.

Alabaster Co. is a publishing company founded in 2016 that blends creativity, beauty, and faith to create visually stunning editions of the Bible and other religious texts. The company was started by Brian Chung and Bryan Ye-Chung, who shared a vision of making the Bible more accessible and engaging, particularly in a world increasingly influenced by visual culture. Their beautifully designed Bibles integrate visual imagery with thoughtful design, transforming traditional biblical texts into artful experiences that resonate with modern readers. Alabaster's mission is to present the story of God as not only spiritually enriching but also aesthetically beautiful. This approach reflects their belief that beauty plays a crucial role in deepening one's connection with faith. The company's products are intended to invite readers into a deeper, more contemplative engagement with the Scriptures, helping them see the Bible in a new light. In addition to Bibles, Alabaster Co. has expanded its offerings to include devotionals, Bible studies, and other home goods, all designed with the same commitment to beauty and quality. Their work has sparked conversations about faith and beauty, making their products popular not just for personal use but also as conversation pieces in homes.

Alliance Ventures is the strategic venture capital arm of the Renault-Nissan-Mitsubishi Alliance, one of the largest automotive groups globally. Launched in 2018, the fund focuses on investing in innovative startups that are transforming the future of mobility. With headquarters in Amsterdam and offices in key innovation hubs such as Silicon Valley, Paris, Yokohama, and Tel Aviv, Alliance Ventures targets early-stage companies developing technologies related to new mobility, autonomous driving, electric vehicles (EV), energy solutions, and connected services. The fund, with an initial capital of $200 million, primarily invests in Series A and B rounds, helping startups scale through strategic collaborations within the Alliance’s vast automotive ecosystem. Notable investments include companies like WeRide (autonomous driving in China), Enevate (battery technology), and The Mobility House (smart charging and energy storage). Alliance Ventures leverages its extensive network to provide not only capital but also partnerships and market access to accelerate startup growth. Led by a seasoned team, including General Secretary Véronique Sarlat-Depotte and Partner Ryan Armbrust, the fund actively supports startups through every growth phase, from early innovation to commercial scaling, aiming to integrate cutting-edge solutions into the Renault-Nissan-Mitsubishi operations.

Altos Ventures, founded in 1996 and based in Menlo Park, California, is a prominent venture capital firm managing over $10 billion in assets. Known for its early-stage investments, Altos Ventures focuses on consumer and enterprise technology companies. Some of their most notable investments include Coupang, Woowa Brothers, Roblox, and Toss, with Coupang achieving a valuation exceeding $100 billion at its IPO​. Altos Ventures typically makes initial investments ranging from $1 to $5 million, aiming to support the full lifecycle of their portfolio companies. They are known for their hands-on approach, providing significant operational support and partnering closely with management teams to build strong, scalable businesses​. Their investment strategy emphasizes strong operating fundamentals and attractive unit economics, targeting emerging opportunities in both the consumer and enterprise sectors. The firm has a significant presence in Asia, particularly in Korea and Japan, where they have successfully backed several unicorns​. Key figures at Altos Ventures include co-founders Han Kim and Ho Nam, who bring extensive experience and a deep understanding of the startup ecosystem. Startups seeking investment from Altos should demonstrate robust business models and the potential for long-term growth.

ANRI is a venture capital firm based in Tokyo, Japan, focusing primarily on seed and early-stage investments. Founded with the mission to drive innovation, ANRI has invested in over 260 companies, emphasizing sectors such as electric vehicles, recycling, manufacturing, and information technology. Notable investments by ANRI include startups like Turing, a manufacturer in the electric vehicle sector, and amu, which focuses on recycling and waste management. Their portfolio showcases a strong commitment to diverse industries, including health tech and fintech. ANRI's investment approach often involves co-investing with other significant players in the market, thereby enhancing their portfolio companies' growth and market reach. ANRI has successfully achieved exits with companies like Raksul, DELY, and Coincheck, highlighting their capability to nurture startups towards profitable outcomes. Their investment philosophy emphasizes supporting innovative ideas that have the potential to make substantial impacts globally. The firm is also committed to diversity and inclusion, having set and achieved goals to increase investments in startups led by women. This dedication to fostering a diverse entrepreneurial ecosystem is part of ANRI's broader strategy to drive meaningful change and innovation in the startup landscape​.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

Archetype is an early-stage venture capital firm that focuses on accelerating the decentralized future, primarily backing startups in the Web3 and cryptocurrency space. Founded in 2021 and based in New York, Archetype is led by founder Ash Egan and a team of experienced professionals from the crypto, investing, and engineering worlds. The firm invests in seed-stage companies, with check sizes typically ranging from $1M to $3M. They also lead many of their funding rounds. Archetype is known for backing founders who are disrupting traditional industries by creating entirely new markets within the decentralized economy. The firm's portfolio includes standout names like Alchemy, Socket, and Mona, all of which focus on cutting-edge technologies in crypto infrastructure, blockchain development, and decentralized applications. Archetype’s investment philosophy is centered on supporting founders with deep technical expertise and a vision for decentralization. They are highly active in the U.S., with a particular focus on startups that bring innovation to financial services, infrastructure, and software development. The firm also provides strategic guidance, leveraging its team’s extensive network within the crypto ecosystem to help startups grow from concept to market-ready products. By combining their expertise in both technology and operations, Archetype positions itself as a critical partner for crypto founders looking to build and scale innovative projects in the decentralized world.

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Artesian Investments, founded in 2004 by Jeremy Colless, Matthew Clunies-Ross, and John McCartney, is a global alternative investment management firm specializing in venture capital, public and private debt, and impact investment strategies. Based in Sydney, the firm has expanded its reach with offices in Melbourne, Adelaide, Shanghai, Jakarta, Singapore, London, and New York​​. Artesian's notable investments include Instaclustr, PouchNATION, and Regrow Ag. They are particularly active in the Asia-Pacific region, managing over $1.22 billion in assets and boasting more than 600 startup investments​ (Artesian)​. Their investment strategy focuses on early-stage ventures across various sectors, including technology, agrifood, medtech, and AI. Artesian also offers a unique "Venture Capital as a Service" (VCaaS) platform, providing customized investment solutions to corporations, government, and family offices​. The firm places a strong emphasis on ESG (Environmental, Social, and Governance) criteria and impact investing, aiming to deliver sustainable returns while addressing critical global challenges. Artesian is a certified B Corp, underscoring their commitment to positive social and environmental impact. Key team members include Jeremy Colless (CEO), Matthew Clunies-Ross (CIO), and Luke Fay (Partner, Australian Venture Capital). Their diversified team spans multiple continents, bringing extensive expertise and a global perspective to their investment activities

Atinum Investment, the venture capital arm of Atinum Partners, is a prominent South Korean investment firm with over $450 million in assets under management. The firm focuses on diverse sectors such as deep tech, artificial intelligence, blockchain, advanced robotics, bio-healthcare, and IT components. They actively invest in early-stage to growth-stage startups with significant global market potential. Notable portfolio companies include CryptoQuant, Allganize, and Klook. Atinum Investment has a global reach, particularly focusing on Southeast Asia, with investments in companies like InstaReM and Fast Five, a South Korean co-working space startup. The team at Atinum Investment includes key figures such as Wan Gee Cho, who specializes in deep tech and SaaS investments, and Peter Na, the Regional Head for Southeast Asia, focusing on investments in the region from the Singapore office. Atinum is committed to providing more than just capital by offering strategic guidance and opening doors to potential customers and partners, ensuring the growth and success of their portfolio companies.

Baidu Ventures is a venture capital firm launched by Baidu in 2016, with a focus on supporting emerging technologies, particularly in artificial intelligence (AI). The firm is headquartered in Beijing, China, and manages over $700 million in assets, with a portfolio of more than 200 active companies worldwide. BV.ai invests in AI-driven industries such as autonomous vehicles, robotics, life sciences, advanced computing, and medical technology. BV.ai is known for being one of the early pioneers in AI venture capital, investing in startups that are developing cutting-edge technologies. The firm primarily targets companies that are at the seed to growth stages, offering capital and strategic guidance to help these businesses scale and achieve significant technological breakthroughs. BV.ai is committed to fostering innovation that can transform industries and have a long-lasting global impact. The firm’s approach includes providing not only financial backing but also technical expertise and resources from Baidu's extensive ecosystem. This gives portfolio companies access to Baidu’s research and development capabilities, helping them stay competitive in fast-evolving markets. BV.ai has successfully supported a variety of startups, including those in the fields of autonomous driving, smart healthcare, and AI-powered enterprise solutions. With a mission to drive the next wave of technological advancements, BV.ai continues to lead the way in AI-focused venture investments, helping entrepreneurs develop groundbreaking solutions that address critical challenges across multiple industries. The firm's strategy is to partner with technology-driven entrepreneurs from the earliest stages, aiming to identify pioneers in various industries. Baidu Ventures not only provides financial backing but also strategic support, leveraging its expertise and Baidu's resources to accelerate growth. Their investments span key sectors such as smart cities, IoT, new energy vehicles, and semiconductors. Led by Xue Gao as CEO and Managing Partner, the firm has gained recognition in China as a top investor in AI and big data, consistently ranking among the best investment institutions in the field. By focusing on long-term value creation, Baidu Ventures aims to foster the development of groundbreaking technologies that can transform industries and improve people's lives globally.

BEENEXT, founded in 2015 by Teruhide Sato, is a venture capital firm based in Singapore that focuses on early-stage technology startups in India, Southeast Asia, Japan, and the USA. The firm invests across diverse sectors, including fintech, healthtech, foodtech, and proptech, aiming to support innovative companies that drive significant change. Notable investments include BharatPe, a leading fintech company in India; NoBroker, a proptech platform in India; Trusting Social, an AI-driven fintech firm; M2P, an open banking platform; and Coins.ph, a digital wallet in the Philippines. BEENEXT has made over 317 investments, and the firm is known for its hands-on approach, leveraging the extensive operational experience and global network of its founders to provide strategic support and mentorship to its portfolio companies. This approach has led to several successful exits, such as Dekoruma, an Indonesian e-commerce platform; Milkbasket, an Indian grocery delivery service; and Coins.ph, which was acquired. The firm operates with a philosophy centered on empowering founders and fostering innovation, with the goal of building scalable and sustainable businesses. BEENEXT is particularly focused on identifying startups that have the potential to make a substantial impact in their respective industries. The firm’s extensive network of advisors and partners further strengthens its ability to support portfolio companies through various stages of growth, from initial funding rounds to scaling and eventual exit strategies.

Beyond Next Ventures, founded in 2014 and based in Tokyo, focuses on early-stage investments in deep tech startups, primarily in Japan and India. The firm invests in various sectors including medtech, healthcare, biotechnology, agriculture, food, digital, space, and climate technology​. Notable investments include companies like MediBuddy, GigIndia, QD Laser, and Susmed. MediBuddy is a significant player in telemedicine and healthcare services in India, while QD Laser and Susmed are notable for their IPOs on the Tokyo Stock Exchange​. Beyond Next Ventures typically leads early-stage financing rounds, offering extensive support through their incubator programs aimed at commercializing advanced research. The firm has about $340 million under management, underscoring its commitment to fostering innovation in deep tech and science-based startups​. The leadership team, including CEO Tsuyoshi Ito and Managing Director Kengo Ueha, brings a wealth of experience and strategic insight, supporting startups through growth management, market entry, and expansion strategies.

Bits x Bites is a Shanghai-based venture capital firm and China’s first dedicated agrifood tech investor. Founded in 2016 by Matilda Ho, the firm focuses on early-stage startups tackling the most critical challenges in the food system, including food security, safety, and sustainability. Their investments span the entire food supply chain, from farm innovations to novel food production technologies, helping to revolutionize agriculture in China and beyond. Bits x Bites manages over $100 million across its funds, with a strong emphasis on scalable technologies that can make a measurable impact on food production and environmental sustainability. Their portfolio includes companies like EAVision, which specializes in autonomous drones for complex farming terrains, and Mojia Bio, a biomanufacturing startup that produces eco-friendly nutrients for the food industry. These investments reflect the firm’s commitment to advancing solutions in precision agriculture, alternative proteins, and biomanufacturing. With a global outlook, Bits x Bites evaluates around 1,200 startups annually, targeting companies with technologies that can be applied in China. They support their portfolio companies through partnerships with industry leaders such as Syngenta and Temasek, offering access to valuable resources and markets. The firm’s multidisciplinary team of experts provides hands-on guidance to help startups scale and commercialize their innovations in the Chinese market, shaping the future of food technology in the region​.

BlueRun Ventures (BRV), founded in 1998 and headquartered in Menlo Park, CA, is an early-stage venture capital firm with a global presence. The firm has offices in the United States, China (Beijing and Shanghai), and South Korea. BRV is known for its focus on mobile, fintech, digital health, and consumer experiences, targeting startups that solve significant problems in these sectors. BRV's portfolio boasts notable investments including PayPal, Waze, Coupa, and Kabbage, showcasing their track record in identifying and nurturing high-potential companies. The firm’s investment strategy involves leading seed and Series A rounds, typically investing between $2 million and $8 million per deal. They prioritize early-stage companies that exhibit strong growth potential and innovative solutions. The BRV team consists of experienced professionals such as co-founders John Malloy and Jonathan Ebinger, who bring deep expertise in mobile software, services, and financial technology. The team leverages its collective experience in product development, marketing, and design to support portfolio companies. Startups looking to engage with BRV should emphasize their potential for disruption and scalability. The firm values entrepreneurs who are pushing industry boundaries and can benefit from BRV’s extensive network and hands-on approach to growth.

Cherubic Ventures is a venture capital firm that specializes in early-stage investments, focusing on transformative industries in both the US and Asia. With over $400 million in assets under management, the firm has a portfolio that includes more than 150 startups. Notable investments include Flexport, Hims & Hers, Calm, Ring, Wish, and Paidy, showcasing their ability to identify and support high-growth potential companies. Founded in 2014 by Matt Cheng, Cherubic Ventures operates from key locations in San Francisco, Taipei, and Beijing. Their investment strategy targets seed-stage companies that have the potential to disrupt industries. They typically invest in sectors such as fintech, health tech, consumer internet, and enterprise software, aiming to back ambitious founders from the earliest stages. Cherubic Ventures is known for its hands-on approach, providing more than just capital. They offer strategic guidance and support to help startups scale. Their active involvement in their portfolio companies has led to successful exits, including high-profile acquisitions and IPOs. The firm’s geographic focus allows them to bridge the gap between Western and Asian markets, providing unique opportunities for startups to expand globally. Cherubic Ventures' team is composed of experienced investors and entrepreneurs who leverage their extensive networks to help startups succeed.

CM Venture Capital, headquartered in Shanghai, China, is an early and growth-stage venture capital firm focusing on investing in hard-tech innovations that drive significant industrial transformations. Founded in 2010, the firm is committed to supporting startups that are developing advanced materials, digital industrial solutions, and technologies for energy and environmental sustainability. CM Venture's investment strategy is centered on predicting future trends and selecting startups poised to become industry leaders. They emphasize deep technological expertise and work closely with portfolio companies to provide strategic guidance and mentorship. Their notable investments include Econic, a UK-based company developing catalysts to incorporate CO2 into materials, and NovoNutrients, a US-based startup producing food and feed from CO2​. The firm collaborates with corporate venture capital arms of multinational companies such as GE, Samsung, and BASF, leveraging their extensive networks and industry experience to help startups scale effectively. Their portfolio spans across various sectors, including 5G, hydrogen energy, automation, and sustainable materials​.

Colopl Next is a venture capital arm of Colopl Inc., a prominent Japanese gaming company, founded in 2015. Colopl Next focuses on investing in startups and publicly listed companies, with a strong emphasis on emerging technologies, B2C services, and the entertainment sector. The firm leverages its extensive knowledge in these areas to support young entrepreneurs and innovative companies globally. The fund's industry focus includes virtual reality (VR), augmented reality (AR), artificial intelligence (AI), blockchain, and other cutting-edge technologies. Notable investments include companies like Flitto and Kaizen Platform, which have successfully gone public. Colopl Next also has a robust presence in sectors like lifestyle services, health, and media content, supporting ventures that align with the theme of "Entertainment in Real Life". Geographically, Colopl Next primarily operates from Tokyo, Japan, but it also invests in international startups, including those in Korea and Southeast Asia. Their investment strategy includes a range of funds, such as the Next Unicorn Fund and several others dedicated to different stages and focuses, from seed investments to more mature stages. Colopl Next is known for its hands-on support approach, providing extensive resources through a network of over 200 portfolio companies, numerous advisors, and experts. This support is augmented by the diverse backgrounds of its team members, including former investment managers and successful entrepreneurs. The leadership team at Colopl Next includes key figures like Naruatsu Baba and Sehong Jang, who bring substantial experience and strategic vision to the firm. Startups seeking investment from Colopl Next are encouraged to showcase innovative technologies and robust growth potential​.

Co-Win Ventures, founded in 2009 and based in Beijing, China, is a prominent early-stage investment firm focusing on the Technology, Media, and Telecommunications (TMT) and healthcare sectors. Their portfolio features a variety of innovative companies, including KBP Biosciences, Celsius Therapeutics, Thrive Earlier Detection, and Fluent BioSciences. The firm supports both early-stage and growth-stage companies, providing capital and strategic guidance to help them scale successfully. Co-Win Ventures has a strong presence in both China and the USA, leveraging its extensive network to foster innovation and growth. Their investment approach combines financial backing with hands-on support, ensuring that their portfolio companies have the resources they need to thrive in competitive markets. By focusing on sectors with high growth potential, Co-Win Ventures aims to drive advancements in technology and healthcare, contributing to significant industry developments. Their commitment to supporting visionary entrepreneurs has made them a key player in the venture capital landscape.

CPT Capital, based in London, is the venture capital arm of a leading private family office. The firm specializes in investing in companies revolutionizing the food and materials technology sectors, particularly in the realm of alternative proteins. CPT Capital's mission is to drive this revolution by partnering with visionary founders and supporting them from pre-seed stages through to IPO or sale. As a long-standing investor in the alternative protein space, CPT Capital focuses on plant-based proteins, biomass fermentation, recombinant proteins, and cultivated meat. Their portfolio includes groundbreaking companies like Impossible Foods, Beyond Meat, and Upside Foods, all of which are at the forefront of developing sustainable and innovative food solutions. CPT Capital seeks companies with products that directly replace animal-derived products and possess a strong technological or intellectual property component. The firm is geographically diverse, with investments spanning the US, Israel, Europe, the UK, and Asia. The firm is dedicated to addressing global challenges related to food production and sustainability, aiming to replace traditional animal protein sources with more sustainable alternatives. This approach not only promises environmental benefits but also aims to improve public health and resource efficiency.

DCM Ventures, founded in 1996 and based in Menlo Park, California, is a prominent venture capital firm known for its extensive portfolio and successful investments. With over $4 billion under management, DCM focuses on early-stage technology companies across the U.S., China, and Japan. Notable investments by DCM Ventures include companies like SoFi, Careem, Fortinet, and Matterport. These companies highlight DCM’s diverse investment strategy, spanning fintech, cybersecurity, consumer internet, and enterprise software. The firm has also backed companies like Bill.com and Musical.ly (now TikTok), which have seen significant growth and success​​. DCM Ventures operates with a global perspective, investing in the three largest technology markets: the U.S., China, and Japan. This strategic approach has enabled DCM to deliver strong returns to its limited partners, with a focus on early-stage SaaS, fintech startups, and consumer internet companies. The firm has seen numerous successful exits, with 254 companies in its portfolio going public or being acquired​​. The leadership team at DCM includes co-founders David Chao and Xinhe Lin, who guide the firm’s global investment strategy and operational support to its portfolio companies. For startups looking to connect with DCM Ventures, demonstrating innovative solutions in high-growth sectors such as fintech, AI, and cybersecurity can align well with the firm’s investment focus​.

DCP Capital is a leading private equity firm specializing in investments across Greater China and Asia. Founded by former senior partners of KKR and Morgan Stanley, DCP Capital brings together over 26 years of investment expertise in the region. The firm’s leadership team, including Co-Founders David Liu and Julian Wolhardt, has an impressive track record of steering successful investments through multiple economic cycles, focusing on sectors such as consumer goods, industrial technology, healthcare, financial services, and agriculture. DCP Capital raised its debut fund, DCP Capital Partners I, in 2019, closing with over $2.5 billion in commitments. This fund was significantly oversubscribed, attracting top-tier global institutional investors, including sovereign wealth funds, pension funds, and family offices. The firm employs a disciplined, value-oriented investment strategy, targeting both buyouts and significant minority stakes in companies poised for growth and industry consolidation. Their approach emphasizes operational improvements and long-term value creation, which has helped DCP build lasting partnerships with management teams across the region. DCP’s portfolio includes high-profile companies such as Ping An Insurance, Mengniu Dairy, and Adopt A Cow, a disruptive dairy company in China. The firm is known for its deep local knowledge combined with world-class investment expertise, enabling it to identify and capitalize on proprietary opportunities in the dynamic Asian market. By focusing on industries with strong growth potential and by improving operational efficiencies, DCP Capital is well-positioned to continue its success in the private equity landscape.

Decent Capital, founded in 2007 by Jason Zeng, co-founder of Tencent, is a prominent venture capital firm with a global presence. The firm focuses on early-stage investments across sectors such as SaaS, consumer internet, frontier tech, and sustainable technology, with investments ranging from pre-seed to Series A stages. Decent Capital’s diverse portfolio includes notable companies like Lime, Cider, and Huizuche. Lime is well-known for its smart scooters and bikes aimed at addressing last-mile transportation issues, while Cider is a direct-to-consumer e-commerce platform for fashion. Huizuche, another significant investment, focuses on car rental services in China. The firm has seen successful exits, such as the acquisition of Oculii and Huizuche, and the IPO of FangDD on NASDAQ in 2019. The firm’s investment strategy emphasizes supporting companies through their growth stages with continued capital and strategic guidance. Decent Capital operates from multiple locations, including offices in Shenzhen, Hong Kong, Singapore, and the United States, ensuring a broad reach and impact across various markets.

DHVC, founded in 2013 by Shoucheng Zhang, is a venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments across several sectors, including enterprise, consumer, fintech, and healthcare. Over the years, DHVC has built a substantial portfolio, investing in over 267 companies with 75 successful exits​. DHVC has also seen significant exits with companies like Wish Shopping, Qeexo, and Namocell, indicating their strong presence in the tech investment space. The firm’s investment strategy involves participating in a mix of seed, early-stage, and later-stage funding rounds, often co-investing with other prominent venture capital firms​. The DHVC team, led by key members such as Kevin Ding and Judy Yan, brings a wealth of experience and a global perspective to their investment approach. The firm’s operations are split between the United States and China, allowing them to leverage opportunities across major innovation hubs​.

DNX Ventures is an early-stage venture capital firm specializing in B2B startups, with a particular focus on SaaS, cybersecurity, fintech, deep tech, sustainability, and retail tech sectors. Founded in 2011, DNX Ventures operates from offices in Silicon Valley and Tokyo, bridging two of the world's most innovative markets. The firm invests in seed and Series A startups, typically providing initial investments ranging from $1 to $5 million. DNX Ventures aims to support founders who are tackling significant challenges for enterprise companies, helping them shape industries and transform the way we live and work. Notable investments by DNX Ventures include Cylance, ICEYE, Movandi, and Nauto. Their approach emphasizes close partnership with portfolio companies, offering extensive support and resources to help them succeed.

East Ventures is one of Southeast Asia's most active venture capital firms, known for backing some of the region's most successful startups. With investments in Tokopedia, Traveloka, Xendit, and Carro, it has a strong track record of nurturing unicorns. The firm primarily focuses on sectors like fintech, healthcare, SaaS, and logistics, with an emphasis on Indonesia, where it helps drive digital and economic growth. Recent investments include AWST (Web3), McEasy (telematics), and Rekosistem (waste management), reflecting its broad sectoral interest. East Ventures typically invests at the seed stage but also participates in growth rounds through its EV Growth Fund. It operates across multiple locations, including Jakarta, Singapore, and Japan, and is deeply committed to sustainability, with goals like achieving net-zero emissions by 2050. The firm supports ESG initiatives across its portfolio and actively engages in environmental projects such as mangrove reforestation. Co-founded by Willson Cuaca, Roderick Purwana, and Melisa Irene, East Ventures is recognized globally, having been ranked among the most active VCs by Pitchbook and CB Insights. The firm maintains a founder-centric philosophy, investing in people and markets over products, which has been key to its long-term success.

Eight Roads Ventures, founded in 1969, is a global venture capital firm and the corporate investment arm of Fidelity International. The firm manages over $11 billion in assets and has a significant presence in major markets including the UK, China, India, Japan, and the US. Eight Roads focuses on investing in technology and healthcare sectors, backing companies from early to growth stages. Eight Roads has built an impressive portfolio with over 300 active companies and 19 unicorns, including notable names like AppsFlyer, Icertis, and Akulaku. The firm is also known for its strong support network, providing not just capital but also strategic guidance and resources to help its portfolio companies scale globally. The firm recently launched a $375 million fund focused on Europe and Israel, targeting sectors such as enterprise technology, consumer, fintech, and healthcare IT. This fund aims to make 15 to 20 investments of $10 million to $30 million each​. Eight Roads' team includes seasoned professionals like Daniel Auerbach, Senior Managing Partner & Head of Global Ventures, and Jarlon Tsang, Managing Partner & Head of China, who bring extensive experience and expertise to the firm's operations.

ENEOS Innovation Partners, the corporate venture capital arm of ENEOS Holdings, was established in October 2019 to drive innovation and sustainability through strategic investments in startups. This CVC focuses on areas such as energy, resources, and materials, with a mission to contribute to a low-carbon and recycling-oriented society. Based in Tokyo, ENEOS Innovation Partners seeks to collaborate with startups that are developing advanced technologies and new business models, aiming to co-create value for the future. The firm's investment strategy centers around five key areas: decarbonization, circular economy, data science, cutting-edge technology, and mobility. ENEOS Innovation Partners not only provides funding but also supports startups with resources like Proof of Concept (PoC) locations, opportunities for business collaboration, and long-term growth partnerships. The portfolio of ENEOS Innovation Partners includes a wide range of companies working on innovative solutions, from autonomous vehicles and renewable energy to battery recycling and sustainable agriculture. Through these investments, the firm aims to accelerate the development of technologies that will shape a sustainable future.

Envisioning Partners, based in Seoul, South Korea, is a leading impact-focused venture capital firm. Founded to address critical global challenges, the firm targets investments in startups that leverage technology and innovation to tackle climate change, improve health and wellness, enhance education, and transform the future of work. Envisioning Partners manages around $140 million in assets and invests primarily in pre-Series A to Series B stages, supporting companies with both capital and strategic guidance. The firm’s commitment to sustainability and social impact is reflected in its diverse portfolio. Envisioning has backed companies such as Shiok Meats (cell-cultured crustaceans), Mango Materials (biodegradable plastics), and H2 (vanadium redox flow batteries for long-duration energy storage). They have also invested in education and health-related startups like Enuma, which provides accessible learning solutions, and Caring, a platform for elderly care services. Envisioning Partners applies a rigorous impact discipline, aligning its investments with the United Nations Sustainable Development Goals (SDGs). The firm offers robust post-investment support through a global network of advisors and industry experts, helping its portfolio companies achieve both financial success and meaningful social impact​.

Esco Ventures, the investment arm of Singapore-based Esco Group, focuses on early-stage life sciences and medtech startups. The firm specializes in areas like biotech, diagnostics, and women’s health, aiming to nurture groundbreaking technologies that improve global health. What sets Esco Ventures apart is its hands-on approach, offering startups more than capital by providing mentoring, productization, manufacturing support, and global distribution networks through its parent company, Esco Group. Esco Ventures plays a crucial role in shaping the next wave of medical innovations, drawing on Esco Group’s decades of experience in life sciences. Their investment philosophy is built around long-term growth, with an emphasis on addressing unmet medical needs through disruptive technologies. The firm has a global reach but maintains a particular focus on Singapore, aligning with the nation’s vision to become a biomedical innovation hub in Asia. Under the leadership of Managing Partner XiangQian Lin, Esco Ventures works closely with scientists, engineers, and entrepreneurs, guiding them from ideation to commercialization. The firm has already seen success with investments like a Danish/Lithuanian medical device company, which achieved 5x growth within three years. Esco Ventures also actively supports the local Singaporean ecosystem by mentoring early-stage researchers and startups even before formal incorporation, fostering a collaborative and innovative environment aimed at creating the next big breakthroughs in life sciences and medtech.

Evonik Venture Capital, the corporate venture arm of Evonik Industries, manages a fund size of €400 million and has made over 50 investments since 2012. The firm strategically invests in innovative startups across various growth fields such as Nutrition & Care, Smart Materials, Specialty Additives, and Digitalization, with a strong focus on sustainability and carbon neutrality technologies​. Evonik's portfolio includes startups like Interface Polymers, which develops additives for easier recycling of plastics, and SuperC, a leader in graphene materials for improving lithium-ion batteries. Other notable investments are Allay Therapeutics, which has developed a post-surgery pain relief implant, and Citrine Informatics, an AI-driven platform for materials and chemicals development​. The venture capital unit emphasizes early to growth-stage investments, with typical investment volumes of up to €15 million per portfolio company. They aim to be an active partner, providing strategic, technical, and commercial support, and leveraging their extensive network for the growth of their portfolio companies. Evonik Venture Capital operates globally with offices in Germany, the USA, and China, making them well-positioned to support innovative startups in key regions worldwide.

Hearst Ventures, established in 1995, is the corporate venture capital arm of Hearst Communications. Based in New York, it operates globally with offices in London, Beijing, and Tel-Aviv. Hearst Ventures has invested over $1 billion to date, making it one of the most active corporate venture funds. The firm focuses on early-stage investments in technology-driven businesses across various sectors, including media, information services, and technology. Notable portfolio companies include Via, a global provider of on-demand transit solutions; Roku, a leading streaming platform; and BuzzFeed, a prominent digital media company. Hearst Ventures has made a total of 199 investments and achieved 84 successful exits, including high-profile companies like Pandora and Brightcove. The leadership team at Hearst Ventures includes Kenneth Bronfin, Senior Managing Director and Head of International Investments; Scott English, Senior Managing Director and Head of U.S. Investments; and Darcy Frisch, Managing Director and Vice President. Their extensive experience and strategic guidance play a crucial role in driving the success of Hearst Ventures' portfolio companies.

FuturePlay, based in South Korea, is a venture capital firm and startup incubator founded in 2014. The firm focuses on early-stage investments in sectors such as healthtech, robotics, and AI, with a particular emphasis on companies that leverage advanced technology to create innovative solutions. Notable investments by FuturePlay include ThePlantEAT, a platform for plant-based diet recommendations, and Mimetics, a company specializing in robotic process automation. The firm has also backed companies like Anchor Node, which focuses on AI-driven knowledge management, and Toggle Insurance Service, a digital insurance platform. FuturePlay has achieved successful exits with companies like Noul, which went public on the Korea Exchange in 2022, and Vuno, a medical AI startup that also had an IPO in 2021. Additionally, FuturePlay has seen several of its portfolio companies acquired, including Sennen, which was acquired by Kraken in 2023. The firm is known for its hands-on approach, providing extensive support to startups through their incubation programs and helping them scale through strategic partnerships and access to a robust network of co-investors.

Global Founders Capital (GFC) is a leading venture capital firm that supports entrepreneurs from the earliest stages of their ventures through to their growth and IPO phases. Founded by Oliver and Marc Samwer, GFC has built an impressive portfolio of successful investments across various sectors, including technology, e-commerce, and fintech. Notable investments by GFC include high-profile companies such as Facebook, Slack, LinkedIn, Zalando, Delivery Hero, Revolut, Canva, HelloFresh, and Jumia. These investments highlight GFC's strategic focus on backing companies that have the potential to become market leaders and define new categories. GFC operates on a global scale, providing comprehensive support to startups across multiple continents. Their platform offers resources and guidance necessary for startups to scale effectively, from seed funding through all stages of growth. This support includes operational assistance and strategic advice, which have been instrumental in the success of their portfolio companies. Overall, GFC's commitment to empowering gifted entrepreneurs and supporting their ventures from inception to market leadership positions it as a key player in the global venture capital landscape.

Hillhouse Capital, founded in 2005 by Lei Zhang, is a global investment management firm with a significant focus on long-term investments in high-quality businesses. The firm manages assets across venture capital, private equity, and public equities. Hillhouse has offices in key financial hubs including Beijing, Hong Kong, Singapore, and New York, allowing it to leverage its extensive global network and local market expertise. Hillhouse is known for its disciplined investment approach, prioritizing business fundamentals, industry insights, and sustainable growth. The firm's investment strategy spans multiple sectors, including healthcare, consumer, technology, financial services, and industrials. Notable investments include Tencent, JD.com, Baidu, and Meituan, reflecting Hillhouse's ability to identify and support leading companies in transformative industries​. The firm's latest venture fund, Hillhouse Venture Fund V, has a size of $1.36 billion and is fully invested. This fund focuses on venture capital investments, supporting innovative startups and early-stage companies with high growth potential.

GMO Venture Partners is a venture capital firm under the GMO Internet Group, specializing in early to growth-stage investments with a focus on technology and fintech sectors. Established in Japan, the firm has expanded its presence globally, with significant activities in Asia and the United States. GMO Venture Partners manages several funds, including the GMO Fintech Fund 7, established in 2021 with JPY 13.3 billion ($121 million), and the GMO Global Payment Fund. The firm has invested in over 210 companies, boasting 18 IPOs and 11 unicorns in its portfolio, such as Kredivo Holdings and Coda Payments. The firm’s investment strategy includes backing innovative startups in sectors like technology infrastructure, AI, IoT, and fintech. They typically participate in Seed to Series C rounds, often co-investing with other leading venture firms. Notable public companies in their portfolio include Mercari and ChatWork, and they have had successful exits with companies like Cloud Credit and bitFlyer. The team at GMO Venture Partners includes experienced professionals such as Erik Ford, US Venture Partner, and Ryu Muramatsu, Founding Partner. The team brings over 40 years of operational and 50 years of investment experience, focusing on supporting and scaling high-potential startups.

Golden Gate Ventures, headquartered in Singapore, is a leading Southeast Asian venture capital firm with a robust portfolio featuring standout investments like Carro, Stripe, Homage, and Gojek. Founded in 2011 by Jeffrey Paine and Vinnie Lauria, the firm has a strong focus on internet and mobile startups, particularly within e-commerce, payments, marketplaces, and SaaS platforms. They have extended their reach to include significant investments in the Middle East and North Africa with their $100 million MENA fund​​. Their investment strategy is characterized by early-stage funding, often leading rounds with an average check size typically ranging from $500,000 to $2 million. Golden Gate Ventures emphasizes long-term partnerships, providing not just capital but also strategic guidance and operational support to help startups scale. They prefer to be approached with a clear, concise pitch that demonstrates market potential and a strong founding team​​. The team includes industry veterans like Michael Lints and Justin Hall, who bring a wealth of experience from diverse sectors. With a presence in key cities like Jakarta, Ho Chi Minh City, and Doha, Golden Gate Ventures continues to bolster its global footprint while maintaining a sharp focus on Southeast Asia​​. For startups looking to connect, networking through mutual connections and participating in regional startup events can be effective. Golden Gate Ventures values resilience and clarity in vision from the founders they choose to back, reflecting their mission to support transformative technology companies across emerging markets.

GSR Ventures, founded in 2004, is a global venture capital firm with over $3.7 billion in assets under management. The firm focuses on early-stage technology companies developing AI-enabled enterprise software, consumer platforms, and healthcare technology. GSR Ventures has a notable track record with investments in companies like Didi Chuxing, Ele.me (acquired by Alibaba), Qunar (NASDAQ: QUNR), and Xiaohongshu. The firm typically invests in transformative companies that have the potential to make a significant impact in their sectors. GSR Ventures operates across the United States, China, and East Asia, supporting its portfolio companies with a team of experienced founders, engineers, physicians, and enterprise executives. Their approach emphasizes deep industry expertise and active partnership with entrepreneurs. Key team members include co-founder and managing partner Richard Lim, and partner Justin Norden, who focuses on digital health investments. GSR Ventures' strategy involves making significant early-stage investments and providing ongoing support as these companies scale​​. For startups seeking investment from GSR Ventures, it is crucial to demonstrate strong potential for innovation and sector disruption. The firm values clear, compelling pitches and prefers engagements through its extensive network of industry connections.

Heda Ventures is a venture capital firm established in 2008 with headquarters in San Jose, California, and additional operations in Hangzhou, China. The firm specializes in early-stage investments in cutting-edge industries, particularly focusing on biotechnology, healthcare, and the technology, media, and telecommunications (TMT) sectors. Heda Ventures has built a robust portfolio of over 67 investments, working closely with startups that are driving innovation in areas such as diagnostic equipment, drug discovery, semiconductors, and medical supplies. The firm is known for its strategic approach to investment, aiming to support companies with high growth potential by providing not just capital but also guidance and access to its extensive global network. This approach helps portfolio companies scale effectively and achieve market success. Heda Ventures has also been involved in significant exits, including companies like Just - Evotec Biologics and DeepMap, which highlight its successful track record in the venture capital space. With a deep commitment to fostering innovation, Heda Ventures continues to focus on transformative technologies that address critical challenges in healthcare and technology, positioning itself as a key player in the venture capital landscape. The firm's ability to bridge the gap between the U.S. and Chinese markets further enhances its capability to nurture and grow companies on a global scale.

The Hina Group, established in 2003, is a leading Chinese investment firm with a strong presence in Beijing, Shanghai, Shenzhen, and San Francisco. They focus on venture capital and private equity, targeting high-tech, enterprise services, and healthcare sectors. Notable investments include Ubox, a leading vending machine company, and Arrail Dental, a prominent dental service provider in China. Hina Group’s strategy emphasizes early to mid-stage investments, typically in Series A and B rounds, with a focus on technology-driven companies in AI, IoT, 5G, and smart manufacturing. Their approach is research-driven, leveraging deep industry expertise and a robust network to add value post-investment, aiding portfolio companies in scaling and achieving successful exits. The team, led by founder and CEO Hong Chen, comprises seasoned professionals with extensive backgrounds in technology and finance. Key members include Lynn Liu and Leon Wang, who bring decades of experience and strategic insight to the firm. Hina Group prefers to be approached through industry connections and values strong entrepreneurial spirit and execution ability in potential investments. With a history of successful exits and a reputation for high-touch service, Hina Group continues to drive innovation and growth across its focus industries​.

IDC Ventures, founded in 2019 and headquartered in Copenhagen, is a venture capital firm that focuses on investing in early to growth-stage companies across fintech, marketplaces, and digital platforms. With a mission to support founders driving digital innovation, IDC Ventures backs companies that are creating generational shifts in industries such as financial services and technology. Their portfolio includes companies like Curve, GoTrendier, and NovoPayment, reflecting their focus on fintech and software solutions. The firm is known for its thesis-driven investment strategy, where it identifies key sectors experiencing behavioral shifts and concentrates its investments to scale these businesses. IDC Ventures typically leads investment rounds, taking an active role in governance and business development to ensure portfolio companies thrive. They also emphasize creating co-investment opportunities and building a valuable network of investors and entrepreneurs across Europe, the US, and Latin America. IDC Ventures’ collaborative approach, combined with its strong ties to over 100 family offices, positions it as a key player in helping startups achieve substantial growth.

IMO Ventures is a venture capital firm focusing on early-stage investments in technology, media, telecommunications (TMT), fintech, consumer, and healthcare industries. The firm is driven by a mission to support entrepreneurship and innovation, leveraging the extensive experience of its partners who were former tech entrepreneurs and industry leaders. The team at IMO Ventures includes Hai Liu, who has a background in electronic engineering and an MBA from MIT Sloan. He has previously worked with GSR Ventures and Samsung Mobile, bringing significant expertise to the firm​. IMO Ventures invests in startups that harness the power of computing and technology to drive change. They believe in supporting entrepreneurs from the ground up, providing not only financial backing but also strategic guidance and industry connections​. Their portfolio features a diverse range of companies, showcasing their commitment to fostering innovation across multiple sectors.

Impact Venture Capital specializes in early-stage investments in cutting-edge technologies, particularly in AI, enterprise software, and digital transformation tools. Notable portfolio companies include Cornami, which focuses on quantum encryption, and Pondera Solutions, acquired by Thomson Reuters. They also led rounds for startups like TaskHuman and Adroit Worldwide, both pivotal in the tech ecosystem. Geographically, Impact VC is centered in Northern California, with a strong focus on U.S.-based startups, although they maintain global connections through their corporate partnerships. Their strategy revolves around leveraging their extensive corporate venture network to foster relationships between startups and Fortune 500 companies, offering more than just capital. They look for scalable, tech-driven solutions that align with the needs of large enterprises, often leading investment rounds. Typically, Impact VC’s check sizes range from $500K to $5M, and they actively co-invest alongside corporate venture capitalists. They are open to cold outreach but emphasize the importance of strong, well-prepared pitches that highlight clear paths to market impact. Key team members include Jack Crawford and Eric Ball, both with deep expertise in venture investments and corporate partnerships. Impact Venture Capital actively builds its deal flow through a combination of strong ties to corporate venture arms and engagement with the Northern California startup community, making them a go-to partner for high-tech, scalable innovations.

Incubate Fund, established in 2010, is a leading early-stage venture capital firm based in Tokyo, Japan. The firm has a significant presence globally, with offices in key locations such as Singapore, Bangalore, Mumbai, São Paulo, and Mountain View. Known for its extensive portfolio, Incubate Fund has invested in over 300 companies and has facilitated numerous successful exits, including notable firms like Pixie Dust Technologies, Sansan, and WealthNavi. Incubate Fund Asia, a branch of the firm, recently announced the first close of its third fund with a target corpus of $50 million. This fund aims to support pre-seed and seed-stage startups across India and Southeast Asia, focusing on sectors such as B2B, B2C, supply chain, and consumer tech. Notable investments by Incubate Fund Asia include Captain Fresh, ShopKirana, and Yulu. The firm’s mission is to empower startups and fuel innovation across Asia. Incubate Fund provides financial support and strategic guidance to help startups achieve market leadership and sustainable growth

iSGS Investment Works, founded in 2014 and headquartered in Tokyo, Japan, is a venture capital firm that focuses on early to late-stage investments. They have a diverse portfolio, with 63 investments to date, primarily in technology-driven sectors such as artificial intelligence, fintech, and consumer products. Notable investments include companies like Startbahn, which focuses on blockchain technology for the art industry, and SOUNDRAW, an AI-driven music creation platform. They have had significant exits, such as ExaWizards and Unipos, highlighting their success in fostering growth in innovative companies. The firm is led by key figures including Makiko Sato, founder and representative partner, Kazuhito Goshima, CEO, and Kei Sugawara, CFO. Their team combines extensive experience in technology and finance to support their portfolio companies effectively.

iangmen Ventures, established in 2015, is an early-stage venture capital firm based in Beijing, China. The firm focuses on investing in tech-driven startups, particularly those in sectors such as artificial intelligence, healthcare, IoT, and enterprise computing. Their strategy revolves around leveraging technological innovation to unlock business value, primarily targeting early-stage companies that show significant growth potential. Jiangmen has invested in over 50 startups across various industries, including notable companies like Hesai Technology and Heisenberg Robotics. The firm is known for its commitment to backing companies involved in frontier technology such as quantum computing, AI-powered platforms, and advanced manufacturing. One of its more recent investments includes MyTwins.ai, a Hangzhou-based AI platform. Co-founded by Vanessa Gao and Qiang Shen, Jiangmen Ventures takes a hands-on approach with portfolio companies, offering not only financial backing but also strategic mentorship to help startups scale effectively. The firm places a strong emphasis on innovative solutions that can disrupt traditional industries and foster industrial upgrades, particularly in China’s rapidly growing tech landscape.

Kadan Capital is a new and active early-stage investor based in Singapore, launched in 2024. In the past 12 months, the fund has made 5 investments in Fintech, B2B SaaS, and AI from Seed to Series A, which makes the firm one of the 10 most active investors in Singapore.

Korea Biomedical Industry Development Institute (KBIC) is a pivotal entity in South Korea's life sciences and biomedical sectors. Established to stimulate innovation and economic growth, KBIC supports a wide range of activities in medical, pharmaceutical, and biological fields, focusing on advanced technologies like AI and regenerative medicine. KBIC operates through various initiatives and partnerships to foster a robust ecosystem for biomedical research and development. Key areas of focus include promoting bio-health exports, enhancing R&D capabilities, and nurturing talent within the bio-health industry. The South Korean government provides substantial funding and regulatory support to boost the global competitiveness of Korean bio-pharma companies. The institute emphasizes international collaboration, participating in global conventions and establishing partnerships with leading research institutions and biopharmaceutical companies worldwide. This approach enhances innovation and facilitates the entry of Korean companies into the global market.